ORILTA
Sun Pharma Global FZE
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86897317 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Docket Number | SAETM-056 |
| Law Office Assigned | L80 |
| Employee Name | HACK, ANDREA R |
Timeline
| 2016-02-04 | Application Filed |
| 2018-01-29 | Abandon |
| 2018-02-21 | Location: TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED |
| 2018-02-21 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Sun Pharma Global FZE |
| Entity Statement | Free Zone Establishment |
| Address | (DMCC Branch)704 Jumeirah Business Ctr 1 Cluster G, JLT, P.O.Box# 643561 Dubai AE |
| Legal Entity Type | |
| Legal Entity State | AE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | (Based on Intent to Use) Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders and immunologically mediated inflammatory disorders(Based on 44(d) Priority Application) Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders and immunologically mediated inflammatory disorders |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2016-02-08 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2016-02-09 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2016-05-12 | 3 DOCK D:Assigned to Examiner |
| SUSPENSION LETTER WRITTEN | 2016-05-16 | 4 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2016-05-16 | 5 GNSL F:First Action |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2016-05-16 | 6 GNS3 O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2016-11-18 | 7 ALIE A:Allowance for Publication |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2016-11-28 | 8 RCCK S: |
| SUSPENSION INQUIRY WRITTEN | 2016-12-02 | 9 CNSI R:Renewal |
| INQUIRY TO SUSPENSION E-MAILED | 2016-12-02 | 10 GNSI S: |
| NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2016-12-02 | 11 GNS2 O:Outgoing Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2017-01-09 | 12 ERSI I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-01-18 | 13 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-01-18 | 14 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2017-01-18 | 15 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2017-01-18 | 16 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2017-01-18 | 17 GNS3 O:Outgoing Correspondence |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2017-07-20 | 18 RCCK S: |
| SUSPENSION INQUIRY WRITTEN | 2017-07-26 | 19 CNSI R:Renewal |
| INQUIRY TO SUSPENSION E-MAILED | 2017-07-26 | 20 GNSI S: |
| NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2017-07-26 | 21 GNS2 O:Outgoing Correspondence |
| ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2018-02-21 | 22 ABN2 O:Outgoing Correspondence |
| ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2018-02-21 | 23 MAB2 O:Outgoing Correspondence |
| UNDELIVERABLE MAIL - CORRESP. REMAILED | 2018-03-06 | 24 UNDR O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 